ArticleOncotarget2016
Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma.
Sara Redaelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
ArticleOncotarget2016
Sara Redaelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.